Timothy Friend Stanton

Title: **The Innovative Contributions of Timothy Friend Stanton**

Introduction

Timothy Friend Stanton, based in Daly City, California, is an accomplished inventor with a notable portfolio comprising 9 patents. His work primarily focuses on therapeutic advancements, particularly in the realm of cancer treatment.

Latest Patents

Stanton's latest patents include groundbreaking innovations such as "Compositions and methods for inhibiting arginase activity." This patent relates to a novel class of compounds capable of inhibiting arginase activity, and it encompasses pharmaceutical compositions that utilize these compounds. Additionally, Stanton has developed methods for treating cancer utilizing these arginase inhibitors. Another significant patent under his name is "Heterocyclic glutaminase inhibitors," which describes novel heterocyclic compounds along with their pharmaceutical preparations. This invention also includes methods of treatment that utilize these newly designed heterocyclic compounds.

Career Highlights

Currently, Timothy Stanton is affiliated with Calithera Biosciences, Inc., a company that specializes in the development of innovative therapeutics for cancer and other serious diseases. His contributions have played a crucial role in advancing the company’s research and development efforts.

Collaborations

Throughout his career, Stanton has collaborated with esteemed colleagues in the field, including Jim W. Li and Lijing Chen. These collaborations have fostered a dynamic exchange of ideas and have further propelled the advancement of therapeutic innovations at Calithera Biosciences.

Conclusion

Timothy Friend Stanton’s inventive spirit and dedication to medical science underscore his significant impact within the pharmaceutical industry. With a series of innovative patents and valuable collaborations, Stanton continues to contribute actively to the field of cancer treatment, paving the way for future advancements in healthcare.